Meta-analysis: pharmacological treatment of pathological gambling

References

• American Psychiatric Association APaDSMTF. Diagnostic and statistical manual of mental disorders : DSM-5. American Psychiatric Association, Arlington, VA (2013).
   Google Scholar
• Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 66(5), 564–574 (2005).
   PubMed Web of Science ®Google Scholar
• Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am. J. Public Health 89(9), 1369–1376 (1999).
   PubMed Web of Science ®Google Scholar
• Muelleman RL, DenOtter T, Wadman MC, Tran TP, Anderson J. Problem gambling in the partner of the emergency department patient as a risk factor for intimate partner violence. J. Emerg. Med. 23(3), 307–312 (2002).
   PubMed Web of Science ®Google Scholar
• Petry NM, Kiluk BD. Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J. Nerv. Ment. Dis. 190(7), 462–469 (2002).
   PubMed Web of Science ®Google Scholar
• National Gambling Impact Study Commission. National Gambling Impact Study Commission Final Report. Natl Gambl. Impact Study Commission Final Report. (1999).
   Google Scholar
• Petry NM, Ammerman Y, Bohl J et al. Cognitive-behavioral therapy for pathological gamblers. J. Consult. Clin. Psychol. 74(3), 555–567 (2006).
   PubMed Web of Science ®Google Scholar
• Oei TP, Raylu N, Casey LM. Effectiveness of group and individual formats of a combined motivational interviewing and cognitive behavioral treatment program for problem gambling: a randomized controlled trial. Behav. Cogn. Psychother. 38(2), 233–238 (2010).
   PubMed Web of Science ®Google Scholar
• Dowling N, Smith D, Thomas T. Treatment of female pathological gambling: the efficacy of a cognitive-behavioural approach. J. Gambl. Stud. 22(4), 355–372 (2006).
   PubMedGoogle Scholar
• Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S. Psychological therapies for pathological and problem gambling. Cochrane Database Syst. Rev. 11, CD008937 (2012).
   PubMedGoogle Scholar
• Hodgins DC, Fick GH, Murray R, Cunningham JA. Internet-based interventions for disordered gamblers: study protocol for a randomized controlled trial of online self-directed cognitive-behavioural motivational therapy. BMC Public Health 13, 10 (2013).
   PubMedGoogle Scholar
• van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr. Drug Abuse Rev. 5(1), 3–31 (2012).
   PubMedGoogle Scholar
• Hodgins DC, Stea JN, Grant JE. Gambling disorders. Lancet 378(9806), 1874–1884 (2011).
   PubMed Web of Science ®Google Scholar
• Problem Gambling R, Treatment Centre MUUOM. Guidelines for screening, assessment and treatment in problem gambling. Monash University, Clayton, Vic (2011).
   Google Scholar
• Pallesen S, Molde H, Arnestad HM et al. Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis. J. Clin. Psychopharmacol. 27(4), 357–364 (2007).
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Schreiber LR. Pharmacological Treatments in Pathological Gambling. Br. J. Clin. Pharmacol. (2012).
   Google Scholar
• Leung KS, Cottler LB. Treatment of pathological gambling. Curr. Opin. Psychiatry 22(1), 69–74 (2009).
   PubMed Web of Science ®Google Scholar
• Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B. Pharmacological treatments of pathological gambling. J. Gambl. Stud. 21(1), 99–110 (2005).
   PubMedGoogle Scholar
• Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br. J. Psychiatry 197(4), 330–331 (2010).
   PubMed Web of Science ®Google Scholar
• Grant JE, Potenza MN, Hollander E et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am. J. Psychiatry 163(2), 303–312 (2006).
   PubMed Web of Science ®Google Scholar
• Toneatto T, Brands B, Selby P. A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling. Am. J. Addict. 18(3), 219–225 (2009).
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol. Psychiatry 49(11), 914–921 (2001).
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J. Clin. Psychiatry 69(5), 783–789 (2008).
   PubMed Web of Science ®Google Scholar
• Black DW, Arndt S, Coryell WH et al. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. J. Clin. Psychopharmacol. 27(2), 143–150 (2007).
   PubMed Web of Science ®Google Scholar
• Saiz-Ruiz J, Blanco C, Ibáñez A et al. Sertraline treatment of pathological gambling: a pilot study. J. Clin. Psychiatry 66(1), 28–33 (2005).
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Potenza MN et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int. Clin. Psychopharmacol. 18(4), 243–249 (2003).
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J. Clin. Psychiatry 63(6), 501–507 (2002).
   PubMed Web of Science ®Google Scholar
• Blanco C, Petkova E, Ibáñez A, Sáiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann. Clin. Psychiatry 14(1), 9–15 (2002).
   PubMedGoogle Scholar
• Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol. Psychiatry 47(9), 813–817 (2000).
   PubMed Web of Science ®Google Scholar
• Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol. Biochem. Behav. 89(3), 298–303 (2008).
   PubMed Web of Science ®Google Scholar
• McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE Jr. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J. Clin. Psychiatry 69(3), 433–440 (2008).
   PubMed Web of Science ®Google Scholar
• Berlin HA, Braun A, Simeon D et al. A double-blind, placebo-controlled trial of topiramate for pathological gambling. World J. Biol. Psychiatry 14(2), 121–128 (2013).
   PubMed Web of Science ®Google Scholar
• Gupta SK. Intention-to-treat concept: A review. Perspect. Clin. Res. 2(3), 109–112 (2011).
   PubMedGoogle Scholar
• The Consort Group. CONSORT Statement: Box 6 - Intention-to-treat analysis,. CONSORT Statement: Box 6 - Intention-to-treat analysis, (2013). (2010).
   Google Scholar
• Potenza MN. Neurobiology of gambling behaviors. Curr. Opin. Neurobiol. (2013).
   PubMedGoogle Scholar
• Conversano C, Marazziti D, Carmassi C, Baldini S, Barnabei G, Dell’Osso L. Pathological gambling: a systematic review of biochemical, neuroimaging, and neuropsychological findings. Harv. Rev. Psychiatry 20(3), 130–148 (2012).
   PubMed Web of Science ®Google Scholar